91爆料

 

Funding Opportunity Notification

ITHS/Primate Center Pilot Ignition Award

Deadline:聽 January 18, 2021

Letter of Intent DUE: December 18, 2020

The Washington National Primate Research Center (WaNPRC) and the Institute of Translational Health Sciences (ITHS) are pleased to sponsor the Ignition Award, which focuses on the use of non-human primate models of human disease.

The purpose of this Ignition Award is to explore innovative areas of nonhuman primate research and generate preliminary data to serve as a basis for submission of new research grant applications.

Details

Number of Awards: up to two (2)

Award amount: up to $75,000 each

Eligibility: Any research scientist or research faculty can apply except those who have received an ITHS/Primate Center Pilot Ignition Award within the previous three (3) years.

 

The Center particularly encourages applications from early-stage investigators and junior faculty.聽 WaNPRC encourages these individuals to take advantage of this opportunity to pursue innovative research projects or collect preliminary data that can provide proof of concept and lead into future funding

 

More information is available at the links below.

OR

The Washington Entrepreneurial Research Evaluation and Commercialization Hub (WE-REACH) is honored to announce that WE-REACH Executive Director and 91爆料SOP Professor of Pharmaceutics Rodney JY Ho has been elected to the rank of NAI Fellow by the 2020 National Academy of Inventors Fellows Selection Committee and Board of Directors.

鈥淒r. Ho has demonstrated a highly prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on the quality of life, economic development, and the welfare of society,鈥� said NAI President Paul R. Sanberg. 鈥淥ur sincere congratulations on this well-deserved recognition of his accomplishments, and it is an honor to welcome him as a Fellow. I look forward to working with Dr. Ho in support of NAI鈥檚 mission to promote the importance of innovation and celebration of academic invention.鈥�

Dr. Ho will be officially welcomed as an NAI fellow at the organization鈥檚 10th Anniversary Annual Meeting event in Tampa, Florida, June 7-9, 2021.

鈥淚 am honored to be elected as a fellow of the National Academy of Innovators and cited for translating biomedical innovations into products making an impact on the quality of life,鈥� said Dr. Ho. 鈥淚 am truly blessed to work with great people 鈥� colleagues, students, post-docs and staff members 鈥� who are committed daily to contributing creatively and collectively toward economic development and the welfare of society. I could not have done this without their commitment and support.鈥�

Dr. Ho is also the founder and director of the Targeted Long-acting Combination Anti-Retroviral Therapeutic (TLC-ART) program. A public-private partnership, TLC-ART features the support of NIH and WHO鈥檚 UNITAID and helps determine which long-lasting drug combinations will most effectively treat HIV in adults and children globally.

For more information about WE-REACH, visit us at聽/we-reach/聽or contact us at聽wereach@uw.edu.